Cornelia Yzer

Cornelia Yzer advises domestic and foreign companies on mergers and acquisitions and on regulatory issues, making them benefit from her many years of experience in industry and in government positions. A particular industry focus is life science and the digital economic. At Luther, Cornelia Yzer coordinates the Health Care & Life Science sector and the practice group Digital Health. Furthermore, Cornelia Yzer advises her clients on all aspects of research funding.

IT Law
Corporate/M&A
Environment & Planning Law, Regulatory

Cornelia Yzer not only has many years of experience as a lawyer but also demonstrable expertise as a manager, chairwoman/member of supervisory boards of companies and major research institutions and also from government positions.

In the past, she inter alia held the following positions:

• Executive employee at Bayer AG
• Chief Managing Director of the German Association of Research-based Pharmaceutical Companies (vfa) (1997-2012)
• Member of the German Parliament (1990-1998), Parliamentary State Secretary at the Federal Ministry for Education, Science, Research and Technology, and Senator for Business, Research and Technology of the State of Berlin
• Chairwoman of the Administrative Board of Investitionsbank Berlin, Chairwoman of the Supervisory Board of BWB, Member of the Strategic Advisory Board of Medidata Inc., New York (USA), Member of the European Advisory Board of the medical products manufacturer Guidant
• Chairwoman of the Boards of Trustees of major research institutions (German Cancer Research Centre (DKFZ), Max Delbrück Centre for Molecular Medicine (MDC))
• Board Member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Cornelia Yzer studied law and business at the Universities of Bochum and Münster (both Germany). She was admitted to the German Bar in 1990.

• The Legal 500 Germany (2020): Mentioned in Industry Focus - Health

• Marktstudie Medizintechnik 2020
• Erste „App auf Rezept“ bereits im August? Digitale-Gesundheitsanwendungen-Verordnung (DiGAV) in Kraft getreten und Leitfaden über das beschleunigte Zulas-sungsverfahren im Fast-Track veröffentlicht
• Gesetzesentwurf zum Patientendaten-Schutzgesetz (PDSG) liegt nun vor – Neues u.a. zur elektronischen Patientenakte und zum E-Rezept
• Bundesministerium für Gesundheit legt Entwurf zum Patientendaten-Schutzgesetz (PDSG) vor und treibt die Entwicklung der elektronischen Patientenakte voran
• BBC-Statement zu den gestrigen Beschlüssen des EU-Sondergipfels zum Brexit
• Brexit and its impact on the Life Science Industry
• Viva Vivy! Die digitale Gesundheits-App - Digital Healthcare und der Datenschutz
• Neue Datenschutz-Pflichten für Arbeitgeber
• Das eHealth-Datenschutz-Labyrinth
• Mittelstand braucht Digitalisierung